Imagen de Portada

Small-Molecule Tyrosinase Inhibitors for Treatment of Hyperpigmentation

Guardado en:
Publicado en:Molecules vol. 30, no. 4 (2025), p. 788
Autor principal: Ni, Xinhua
Otros Autores: Luo, Xinyu, Jiang, Xiaoying, Chen, Wenchao, Bai, Renren
Publicado:
MDPI AG
Materias:
Crystal structure
Physiology
Copper
Medical prognosis
Metastasis
Melanoma
Oxidation
Enzymes
Kinases
Radiation therapy
Biosynthesis
Skin cancer
Proteins
Molecules
Acceso en línea:Citation/Abstract
Full Text + Graphics
Full Text - PDF
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
Resumen:Increasing attention is being focused on skin health currently, especially the excessive deposition of melanin in the skin. Tyrosinase, the rate-limiting enzyme in melanin biosynthesis, is a crucial enzyme in melanin synthesis. However, existing tyrosinase inhibitors pose some degree of toxicity to humans. Therefore, the development of more efficient and low-toxicity tyrosinase inhibitors is urgently needed. This review briefly depicts the melanin biosynthesis process and the crystal structure and catalytic mechanism of tyrosinase. The latest research progress regarding small-molecule tyrosinase inhibitors is also reviewed. Moreover, the structure–function relationships are analyzed and summarized. This is expected to provide new and more scientific insights to enable researchers to explore safer and more potent tyrosinase inhibitors.
ISSN:1420-3049
DOI:10.3390/molecules30040788
Fuente:Health & Medical Collection